Parkinson's Disease is a neurological condition characterized by motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability, as well as non-motor symptoms including cognitive impairment, mood disorders, and autonomic dysfunction.

It is a progressive disorder that can affect individuals of all ages, although it is more common in older adults, and typically requires long-term management.

Over time, research has advanced from viewing Parkinson's disease merely as a motor disorder to understanding its complex mechanisms involving genetic, neurobiological, and environmental factors.

This evolving understanding has been crucial in developing current therapeutic approaches that aim to manage symptoms, improve overall functioning, and address the multifaceted components of the disease.

iNGENū's team of experienced researchers and clinicians specializes in designing and conducting innovative studies. By leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for Parkinson's disease..